The four hub genes (APOE, BST1, BGN, C1QB) with differential expression in endometrial cancer tissues may serve as potential therapeutic targets, warranting further research to validate their effectiveness as potential prognostic markers and treatment targets for endometrial cancer. This evidence concerns the gene APOE and endometrial cancer.